Source: iQoncept / Shutterstock
Purple Biotech (NASDAQ:PPBT) just reported results for the first quarter of 2024.
- Purple Biotech reported earnings per share of -14 cents. This was above the analyst estimate for EPS of -19 cents.
- The company did not report any revenue for the quarter.
Article printed from InvestorPlace Media, https://investorplace.com/earning-results/2024/05/ppbt-stock-earnings-purple-biotech-for-q1-of-2024/.
©2024 InvestorPlace Media, LLC